By Connor Hart
Shares of Afya climbed after the company logged higher sales and a better-than-expected profit in the fourth quarter.
The stock gained 12%, to $18.22, in midday trading Friday. Shares--on pace for their largest percent increase in nearly five years--have rallied 17% in the past three months, despite being down 15% in the past year.
The Brazilian medical-education group after the bell Thursday posted a profit of 154.3 million Brazilian reais ($26.6 million), or BRL1.66 a share, compared with net income of BRL101.9 million, or BRL1.09 a share, a year earlier.
Adjusted per-share earnings came in at BRL2.10 a share, topping the BRL1.61 that analysts surveyed by FactSet expected.
Revenue increased 16%, to BRL849 million, and came in just below the BRL850.1 million that analysts modeled.
For 2025, Afya guided for revenue of BRL3.67 billion to BRL3.77 billion, the midpoint of which was in line with analyst expectations, according to FactSet.
Also on Thursday, the company declared its first dividend of BRL1.35, payable in U.S. dollars.
The payout--equivalent to 23 cents quarterly, or 92 cents annually--represents an annual yield of about 5.7% based on its most recent close of $16.22. The dividend will be paid April 4 to shareholders of record as of March 26.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
March 14, 2025 12:10 ET (16:10 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.